- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PSMB10/MECL1 antibody [EPR14902] (AB183506)
Immunohistochemical analysis of paraffin-embedded Human Kidney adenocarcinoma tissue labeling PSMB10/MECL1 with ab183506 at 1/100 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.
Perform heat mediated antigen retrieval with EDTA buffer pH 9 before commencing with IHC staining protocol.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-PSMB10/MECL1 antibody [EPR14902] (AB183506)
Intracellular flow cytometric analysis of Daudi cells (2% paraformaldehyde-fixed) labeling PSMB10/MECL1 with ab183506 at 1/90 dilution (red) or a rabbit IgG (negative) (green), followed by Goat anti rabbit IgG (FITC) secondary at 1/150 dilution.
- WB
Lab
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (AB183506)
Lanes 1-4 : Merged signal (red and green). Green - ab183506 observed at 29 kDa. Red - loading control ab8245 observed at 36 kDa.
ab183506 Anti-PSMB10/MECL1 antibody [EPR14902] was shown to specifically react with PSMB10/MECL1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab264923 (knockout cell lysate ab258145) was used. Wild-type and PSMB10/MECL1 knockout samples were subjected to SDS-PAGE. ab183506 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (ab183506) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human PSMB10 (MECL1) knockout HeLa cell lysate (<a href='/ko/products/cell-lysates/human-psmb10-mecl1-knockout-hela-cell-lysate-ab258145'>ab258145</a>) at 20 µg
Lane 3:
Daudi cell lysate at 20 µg
Lane 4:
Raji cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/ko/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa
false
- WB
Lab
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (AB183506)
Western blot : Anti-PSMB10/MECL1 antibody [EPR14902] ab183506 staining at 1/1000 dilution, shown in green; Mouse anti alpha Tubulin ab7291 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 25,29 kDa in Wild-type HeLa cell lysates with no signal observed at this size in PSMB10 knockout HeLa cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (ab183506) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysates at 40 µg
Lane 2:
Western blot - Human PSMB10 (MECL1) knockout HeLa cell line (<a href='/ko/products/cell-lines/human-psmb10-mecl1-knockout-hela-cell-line-ab264923'>ab264923</a>) at 40 µg
Lane 3:
Daudi cell lysates at 20 µg
Lane 4:
Raji cell lysates at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 29 kDa
Observed band size: 29 kDa,25 kDa
false
- WB
Supplier Data
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (AB183506)
All lanes:
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (ab183506) at 1/1000 dilution
Lane 1:
Human fetal spleen tissue lysate at 10 µg
Lane 2:
Human fetal thymus tissue lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated antibody at 1/1000 dilution
Predicted band size: 29 kDa
false
- WB
Supplier Data
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (AB183506)
All lanes:
Western blot - Anti-PSMB10/MECL1 antibody [EPR14902] (ab183506) at 1/5000 dilution
Lane 1:
HuT 78 cell line lysate at 10 µg
Lane 2:
Raji cell line lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated antibody at 1/1000 dilution
Predicted band size: 29 kDa
false
관련 conjugated 항체와 다양한 조성의 항체 (2)
-
Anti-PSMB10/MECL1 antibody [EPR14902] - BSA and Azide free
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-PSMB10/MECL1 antibody [EPR14902]
Reactivity 정보
제품 세부 정보
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 기간
적절한 단기 보관 조건
적절한 장기 보관 조건
분주 정보
보관 정보
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PSMB10/MECL1 plays a significant role in immune responses. It forms part of the immunoproteasome a variant of the proteasome complex which enhances the generation of antigenic peptides presented on MHC class I molecules. This function is essential for effective immune surveillance and initializing adaptive immunity. In particular PSMB10's influence on antigen processing positions it as an important player in modulating immune system activity.
Pathways
PSMB10/MECL1 participates in pathways associated with protein catabolism and immune signaling. It is involved in the ubiquitin-proteasome pathway which is critical for maintaining cellular protein balance. The function of PSMB10 within the immunoproteasome links it to immune signaling pathways. It has associations with other 20S proteasome subunits such as PSMB8 and PSMB9 which also contribute to the formation of the immunoproteasome complex.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (16)
Recent publications for all applications. Explore the 전체 목록and refine your search
Journal of experimental & clinical cancer research : CR 44:170 PubMed40462177
2025
Applications
Unspecified application
Species
Unspecified reactive species
iScience 28:111873 PubMed40060909
2025
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 122:e2419607122 PubMed39964708
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology and toxicology 40:82 PubMed39320524
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:14087 PubMed35982220
2022
Applications
Unspecified application
Species
Unspecified reactive species
Immune network 22:e28 PubMed35799704
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports. Medicine 2:100455 PubMed35028603
2021
Applications
Unspecified application
Species
Unspecified reactive species
Neuropathology and applied neurobiology 47:1019-1032 PubMed34048071
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 11:603278 PubMed33552061
2021
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in cell and developmental biology 8:592048 PubMed33195259
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com